| Issue |
Section |
Title |
File |
| Vol 50, No 6 (2016) |
Drugs |
Pharmaceuticals for Binary Radiotherapy and Their Use for Treatment of Malignancies (A Review) |
|
| Vol 50, No 6 (2016) |
Structure of Chemical Compounds, Methods of Analysis and Process Control |
Issues Related to Patent Protecton of Darunavir and its Analogs |
|
| Vol 50, No 8 (2016) |
Article |
Synthesis and Antiproliferative Activity of New Acylcatechins |
|
| Vol 51, No 7 (2017) |
Medicinal Plants |
Preparation of Nuflein - an Alkaloid from the Yellow Waterlily Nuphar Lutea - and its Cytotoxic Action on Cultures of Normal and Tumorous Human Cells |
|
| Vol 51, No 9 (2017) |
Drugs |
Sites of Action of Subtoxic Doses of the Iodine-Containing X-Ray Contrast Medium Iopromide on the Kidney and the Search for Means of Preventing the Development of Nephropathy |
|
| Vol 51, No 11 (2018) |
Structure of Chemical Compounds, Methods of Analysis and Process Control |
Analytical Control of Darunavir Tablet Dosage Forms. Part I. |
|
| Vol 52, No 3 (2018) |
Article |
Synthesis and Antioxidant and Cytotoxic Activity of New Dihydroquercetin Derivatives |
|
| Vol 52, No 6 (2018) |
Structure of Chemical Compounds, Methods of Analysis and Process Control |
Methods for Analytical Control of Darunavir Tablet Dosage Forms. Part II |
|
| Vol 52, No 10 (2019) |
Article |
Binding Constants of Maackia Amurensis Whole Extract and its Separate Flavanoids to Estradiol Receptors |
|
| Vol 52, No 12 (2019) |
Structure of Chemical Compounds, Methods of Analysis and Process Control |
HPLC-MS Method for Simultaneous Quantitative Determination of an Innovative Russian Gestagen and its Metabolites in Rat and Rabbit Blood Sera |
|
| Vol 53, No 1 (2019) |
Medicinal Herbs |
Preparation of a Horse Chestnut Extract with a 50% Content of Escin and its Actions on Tumor Cell Proliferation and Isolated Mitochondria |
|
| Vol 53, No 7 (2019) |
Drug Synthesis Methods and Manufacturing Technology |
Relaxivity of Paramagnetic Complexes of Manganese and Gadolinium |
|
| Vol 53, No 9 (2019) |
Discussion |
On Secondary Patenting of Organic Compounds Suitable for use as Active Pharmaceutical Ingredients |
|
